Diabetes Mellitus Following Cisplatin Treatment

Author： Nan Daniel N.   Nan Daniel N.   Nan Daniel N.   Nan Daniel N.   Nan Daniel N.   Nan Daniel N.   Nan Daniel N.  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.42, Iss.1, 2003-01, pp. : 75-78

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of Diabetes Mellitus on Treatment Outcomes in Patients with Nasopharyngeal Cancer

By  

Medical Oncology, Vol. 23, Iss. 3, 2006-09 ,pp. : 341-346

Humana Press, Inc

Access to resources Recommend Favorite

Identification of a proliferatoractivated receptor-γ antagonist for the treatment of type 2 diabetes mellitus

By  

Experimental and Therapeutic Medicine, Vol. 9, Iss. 2, 2015-01 ,pp. : 446-450

Spandidos Publications

Access to resources Recommend Favorite

Changes in MYCN expression in human neuroblastoma cell lines following cisplatin treatment may not be related to MYCN copy numbers

By                

Oncology Reports, Vol. 29, Iss. 6, 2013-01 ,pp. : 2415-2421

Spandidos Publications

Access to resources Recommend Favorite

Identification of a selective glucocorticoid receptor ligand for the treatment of chronic inflammation in type 2 diabetes mellitus

By          

Experimental and Therapeutic Medicine, Vol. 8, Iss. 4, 2014-01 ,pp. : 1111-1114

Spandidos Publications

Access to resources Recommend Favorite

Autologous bone marrow stem cell transplantation for the treatment of postoperative hand infection with a skin defect in diabetes mellitus: A case report

By Liu Yihong   Liu Yuchen   Wang Pujie   Tian Haoming   Ai Jianzhong   Liu Yangbo   Zhou Yi   Liu Zhongwen   Guo Wenjun   Yang Shenke  

Oncology Letters, Vol. 7, Iss. 6, 2014-06 ,pp. : 1857-1862

Spandidos Publications

Access to resources Recommend Favorite